KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardant Health (GH) Change in Account Payables (2017 - 2022)

Historic Change in Account Payables for Guardant Health (GH) over the last 6 years, with Q3 2022 value amounting to $6.7 million.

  • Guardant Health's Change in Account Payables rose 395144.51% to $6.7 million in Q3 2022 from the same period last year, while for Sep 2022 it was $19.5 million, marking a year-over-year increase of 120141.56%. This contributed to the annual value of $8.6 million for FY2021, which is 20991.22% up from last year.
  • As of Q3 2022, Guardant Health's Change in Account Payables stood at $6.7 million, which was up 395144.51% from $11.8 million recorded in Q2 2022.
  • In the past 5 years, Guardant Health's Change in Account Payables registered a high of $12.0 million during Q1 2021, and its lowest value of -$12.0 million during Q2 2020.
  • Its 5-year average for Change in Account Payables is $1.5 million, with a median of $1.7 million in 2021.
  • In the last 5 years, Guardant Health's Change in Account Payables plummeted by 32234.99% in 2020 and then surged by 395144.51% in 2022.
  • Over the past 5 years, Guardant Health's Change in Account Payables (Quarter) stood at $1.7 million in 2018, then surged by 130.57% to $3.9 million in 2019, then tumbled by 322.35% to -$8.7 million in 2020, then skyrocketed by 119.52% to $1.7 million in 2021, then soared by 292.17% to $6.7 million in 2022.
  • Its Change in Account Payables was $6.7 million in Q3 2022, compared to $11.8 million in Q2 2022 and -$753000.0 in Q1 2022.